Hal R. Werner
Founder at HealthCare Ventures LLC
Hal R. Werner active positions
| Companies | Position | Start | End |
|---|---|---|---|
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Founder | 03/05/2010 | - |
| Private Equity Investor | 31/12/1984 | - | |
Innomab, Inc.
 Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | Director/Board Member | - | - |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Director/Board Member | 29/10/2008 | - |
Career history of Hal R. Werner
Former positions of Hal R. Werner
| Companies | Position | Start | End |
|---|---|---|---|
| XENCOR, INC. | Director/Board Member | 30/09/2006 | 19/03/2014 |
| Independent Dir/Board Member | 30/09/2006 | 19/03/2014 | |
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Director/Board Member | 30/11/1999 | 19/03/2010 |
| GENVEC INC | Director/Board Member | 31/12/2001 | 29/09/2007 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Director/Board Member | - | - |
DecImmune Therapeutics, Inc.
 DecImmune Therapeutics, Inc. BiotechnologyHealth Technology DecImmune Therapeutics, Inc. develops novel peptides and antibodies for acute and tissue damaging inflammation. It engages in developing an antibody-based therapeutic that can prevent tissue damage and preserve organ function by inhibiting activation of the N2 neoepitope in the innate autoimmune pathway. The company was founded by Michael Carroll, Richard S. Foemmel, and Francis Moore Jr. on March 27, 2001 and is headquartered in Cambridge, MA.^ | Director/Board Member | - | - |
Asterand Biosciences, Inc.
 Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Director/Board Member | - | - |
| ░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░ ░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Hal R. Werner
| Princeton University | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Statistics
International
| United States | 17 |
| Belgium | 2 |
Operational
| Director/Board Member | 12 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectoral
| Health Technology | 12 |
| Finance | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| XENCOR, INC. | Health Technology |
| Private companies | 13 |
|---|---|
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
DecImmune Therapeutics, Inc.
DecImmune Therapeutics, Inc. BiotechnologyHealth Technology DecImmune Therapeutics, Inc. develops novel peptides and antibodies for acute and tissue damaging inflammation. It engages in developing an antibody-based therapeutic that can prevent tissue damage and preserve organ function by inhibiting activation of the N2 neoepitope in the innate autoimmune pathway. The company was founded by Michael Carroll, Richard S. Foemmel, and Francis Moore Jr. on March 27, 2001 and is headquartered in Cambridge, MA.^ | Health Technology |
Asterand Biosciences, Inc.
Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Health Technology |
Innomab, Inc.
Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | Health Services |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
| Robert S. First, Inc. | |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
Oriel Therapeutics, Inc.
 Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oriel Therapeutics, Inc. develops inhaled drug delivery systems for respiratory diseases and diagnostics. It is a respiratory drug delivery and development company serving the pharmaceutical, biotechnology and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and chronic obstructive pulmonary disease. The company was founded by Paul J. Atkins, Timothy M. Crowder, Richard Fuller and Anthony J. Hickey in 2002 and is headquartered in Durham, NC. | Health Technology |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Hal R. Werner
- Experience
